Chapter 1. Using Facebook, Twitter, and LinkedIn to Explain VC Valuation Gains and Losses: How VCs, Angels, Founders, and Employees Give Up Investment Cash Flow Every Day
Chapter 2. Should Venture-Backed Companies Even Consider a DCF Model? Introducing the Life Science Valuation Case: Zogenix
Chapter 3. Valuation Methods versus Allocation Methods Regarding Zogenix
Chapter 4. Applying the Typical DCF Model to a Venture-Backed Company Hardly Ever Works
Chapter 5. "Enterprise Value" + "Allocation Methods" = Value Destruction: Undervaluing Companies and Overvaluing Employee Options
Chapter 6. Why You Should D.O.W.T. (Doubt) Venture Capital Returns
Option Pool Reserve
Chapter 7. If Valuation Can't Make You Money, Do You Really Need It?: Learning Practical Applications from Kayak.com
Chapter 8. Don't Hate the Appraiser (Blame the Auditor Instead)
Chapter 9. Don't Blame the Auditors (Blame the Practice Aid Instead): 409A Valuation Professionals Discussing Topic 820 (FAS 157) With VC CFOs
Chapter 10. Now That You Understand Venture Capital Valuation, Share It.